U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07035093) titled 'A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain' on May 28.
Brief Summary: The main purpose of this study is to evaluate the efficacy and safety of retatrutide in relieving chronic low back pain in participants who have obesity or overweight. Participation in the study will last about 80 weeks.
Study Start Date: June, 2025
Study Type: INTERVENTIONAL
Condition:
Obesity
Overweight
Chronic Low Back Pain (CLBP)
Intervention:
DRUG: Retatrutide
Administered SC
DRUG: Placebo
Administered SC
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Eli Lilly and Company
Published...